Afshan Shirkavand

Afshan Shirkavand


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in Optical and Quantum Electronics
Verified
Journal Article
Closed access
PDF file
ASAfshan Shirkavand
Afshan Shirkavand
Valery TuchinValery Tuchin
Valery Tuchin
FJFazel Jahangiri
Fazel Jahangiri
EMEzeddin Mohajerani
Ezeddin Mohajerani

7 October 2023 in Clinical Spectroscopy
Verified
Journal Article
Open access
ASAfshan Shirkavand
Afshan Shirkavand
MBMozhdeh Babadi
Mozhdeh Babadi
LFLeila Ataie Fashtami
Leila Ataie Fashtami
EMEzeddin Mohajerani
Ezeddin Mohajerani

15 May 2019 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
ASAfshan Shirkavand
Afshan Shirkavand
SFShirin Farivar
Shirin Farivar
EMEzeddin Mohajerani
Ezeddin Mohajerani
LALeila Ataie‐Fashtami
Leila Ataie‐Fashtami
MGMohammad H. Ghazimoradi
Mohammad H. Ghazimoradi

11 November 2023 in Journal of lasers in medical sciences
Verified
Journal Article
Open access
PDF file
ASAfshan Shirkavand
Afshan Shirkavand
MTMaryam Akhavan Tavakoli
Maryam Akhavan Tavakoli
ZEZeinab Ebrahimpour
Zeinab Ebrahimpour
Introduction: Low-level laser therapy (LLLT), also called Photobiomodulation, has gained widespread acceptance as a mainstream modality, particularly in the form of photobiostimulation (PBM). Here in our review, we aim to present the application of LLLT to help with depression, explore potential action mechanisms and pathways, discuss existing limitations, and address the challenges associated with its clinical implementation. Method: In biological systems, the visible light with a wavelength range of 400–700 nm activates photoreceptors involved in vision and circadian rhythm regulation. The near-infrared (NIR) light with a wavelength range of 800-1100 nm exhibits superior tissue penetration capabilities compared to the visible light, which enables the non-invasive application of LLLT to various tissues. Results: By enhancing adenosine triphosphate (ATP) production using the respiratory chain, LLLT is able to enhance blood flow, reduce inflammation, support repair and healing, and enhance stem cell growth and proliferation. Preclinical studies using animal models have shown promising neuroprotective effects of the LLLT method on central nervous system (CNS) diseases, suggesting potential improvements in brain function for patients suffering from Alzheimer’s disease. In addition, it helps Parkinson’s patients with their movement problems and ameliorates mental disorders in individuals with depression. Conclusion: patients’ quality of life can be significantly enhanced. A comprehensive understanding of the protective effects and underlying mechanisms of LLLT will facilitate its therapeutic application in the future.

1 January 2021 in Journal of lasers in medical sciences
Verified
Journal Article
Open access
PDF file
NZNasrin Zand
Nasrin Zand
LALeila Ataie-Fashtami
Leila Ataie-Fashtami
PMParvin Mansouri
Parvin Mansouri
MFMohsen Fateh
Mohsen Fateh
ASAfshan Shirkavand
Afshan Shirkavand
Introduction: Behçet’s disease (BD) is a debilitating and chronic vasculitis which can affect multiple organs. Recurrent oral aphthosis is the most common clinical feature of BD. The remarkable pain associated with painful oral ulcers can exert a major impact on the patients’ quality of life. Relieving pain of these oral ulcers is an essential approach in the management of mucocutaneous lesions of BD. Non-thermal CO2 laser therapy (NTCLT) as a novel photobiomodulative approach has recently been used for significant and immediate pain reduction of some types of painful oral lesions such as recurrent aphthous stomatitis, pemphigus vulgaris, and so on. In this procedure by some considerations, the conventional CO2 laser is used as a non-surgical, non- thermal, photobiomodulative laser without any visible thermal adverse effects. In this article, we report our experiences about the analgesic effects of NTCLT on painful oral aphthous ulcers of BD. Case Presentation: We report four cases of BD, whose painful oral aphthous ulcers were irradiated with NTCLT. Immediately after NTCLT, the pain of the lesions was significantly relieved with no visible complications. Conclusion: The results of this study suggest that NTCLT could be proposed as a hopeful procedure for significant and instant pain relief of oral aphthous ulcers of BD without any visible thermal adverse effects.

1 January 2021 in Journal of lasers in medical sciences
Verified
Journal Article
Open access
PDF file
MRMohammad Reza Razzaghi
Mohammad Reza Razzaghi
MGMohammad Hossein Ghazimoradi
Mohammad Hossein Ghazimoradi
SAShervin Afzali
Shervin Afzali
EKEhsan Kamani
Ehsan Kamani
EMEzeddin Mohajerani
Ezeddin Mohajerani
SFShirin Farivar
Shirin Farivar
Introduction: The cytotoxicity of chemotherapy drugs is a significant challenge in the way of surmounting cancer. Liposomal drug delivery has proven to be efficacious in increasing the function of the drugs. Its potential to accumulate drugs in the target site and enhance the efficiency of anti-cancer agents with lower doses hinders their cytotoxicity on normal healthy cells. Since the release of drugs from liposomes is not generally on a controlled basis, several studies have suggested that external stimuli including lasers could be used to induce controlled release and boost the efficiency of liposomal drug delivery systems (LDDSs). Methods: The A375 cancer cell line was used and exposed to the liposomes containing doxorubicin in the presence of a low-level laser beam to investigate its effect on the liposomal stimuli-responsiveness release and its toxicity on cancer cells. So as to achieve that goal, Annexin V/PI was employed to analyze the number of cells that underwent apoptosis and necrosis. Results: Here, we report the effect of laser irradiation on LDDSs. According to the results obtained from the annexin V/PI assay, the pattern of viability status has shifted, so that the number of pre-apoptotic cells treated with liposomal doxorubicin and a laser beam was more than that of cells treated with only liposomal doxorubicin. Conclusion: The use of stimuli-responsive LDDSs, in this case, laser-responsive, has led to favorable circumstances in the treatment of cancer, offering enhanced cancer cell cytotoxicity.